Nektar Therapeutics - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released
 |
|---|
| companiesandmarkets.com |
2009-11-10 02:25:03 -
Nektar Therapeutics - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com www.companiesandmarkets.com/Summary-Company-Profile/nektar-thera ..
Nektar Therapeutics - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Nektar Therapeutics, a biopharmaceutical company engaged in the development of differentiated therapeutics with the PEGylation and pulmonary drug development technology platforms. The company has two lead products in development namely Oral NKTR-118 and NKTR-102. It is developing a strong pipeline of novel therapeutics based on its advanced polymer conjugate chemistry
technology platform. The company is headquartered in California, United States.
The Nektar Therapeutics - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
